Avadel Pharmaceuticals has entered into an asset purchase agreement with Cerecor, whereby Cerecor will acquire the Avadel pediatric portfolio. In connection with this transaction, Avadel and Cerecor will enter into a license and development agreement pursuant to which Avadel will develop up to four product formulations for Cerecor using Avadel’s LiquiTime and Micropump technologies. Under the asset purchase agreement, Cerecor will acquire the company’s four commercial pediatric produ...